ICD-10-CM Billable Code

H95.02

Recurrent cholesteatoma of postmastoidectomy cavity, left ear

Clinical Classification Guidelines

Medical Intelligence & Overview

Recurrent cholesteatoma of the postmastoidectomy cavity is a condition characterized by the abnormal growth of keratinizing squamous epithelium within the surgically created space behind the ear. This condition particularly affects individuals who have undergone mastoidectomy—a surgical procedure often performed to treat chronic middle ear infections. When cholesteatoma recurs after such surgery, it can cause damage to nearby structures, leading to hearing loss, infections, or other complications. The ICD-10 code H95.02 is assigned to this specific diagnosis, indicating a recurrent cholesteatoma in the left ear’s postmastoidectomy cavity.

Causes & Symptoms

Clinical Causes: Incomplete removal of cholesteatoma tissue during initial surgery Re-entry of skin cells into the postmastoidectomy cavity Chronic ear infections leading to tissue proliferation Altered ear anatomy post-surgery that promotes keratin buildup Genetic predisposition to abnormal epithelial growth

Key Symptoms: Persistent or recurrent, foul-smelling ear discharge (otorrhea) Hearing loss or worsening hearing over time A feeling of fullness or pressure in the affected ear Tinnitus (ringing or buzzing in the ear) Occasional ear pain or discomfort Dizziness or balance issues in some cases Recurrent infections despite treatment

Diagnostic & Treatment

Diagnosis Path: Diagnosis is typically made through a combination of clinical examination and imaging studies. An otolaryngologist will perform an otoscopic examination to visualize the postmastoidectomy cavity for signs of cholesteatoma growth, such as abnormal tissue or debris. Imaging techniques like high-resolution computed tomography (CT) scans of the temporal bone help assess the extent of the lesion and evaluate any involvement of surrounding structures. Occasionally, surgery may be necessary to confirm the diagnosis and fully remove the cholesteatoma tissue.

Treatment Protocols: Treatment primarily involves surgical intervention to remove the recurrent cholesteatoma and prevent further complications. The options include: - **Surgical removal (cholesteatoma surgery)**, which may involve re-operation on the mastoid or middle ear to excise the abnormal tissue. - **Postoperative care** with antibiotics to manage and prevent infection. - **Regular follow-up examinations** to monitor for recurrence. - **Hearing rehabilitation** may be considered if hearing loss persists after treatment. In some cases, additional procedures like canal wall reconstruction may be required to optimize ear function and reduce the risk of future cholesteatoma formation.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H95.02 a billable ICD-10 code?
Yes, H95.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H95.02?
Clinical documentation must specify the nature of Recurrent cholesteatoma of postmastoidectomy cavity, left ear and any associated comorbidities for accurate reporting.

Cite this Clinical Reference